Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

Punt, CJA; Keizer, HJ; Douma, J; Schuller, J; Skovsgaard, T; ten Napel, CHH; Lochs, H; Muller, EW; Russell, L; Wagener, DJT

File(s) not publicly available

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

journal contribution

posted on 2023-06-22, 05:05 authored by CJA Punt, HJ Keizer, J Douma, J Schuller, T Skovsgaard, CHH ten Napel, H Lochs, EW Muller, L Russell, DJT Wagener

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

History

Journal

EUROPEAN JOURNAL OF CANCER

Volume

35

Pagination

S68-S68

Publisher DOI

https://doi.org/10.1016/S0959-8049(99)80638-8

ISSN

0959-8049

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083068300203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Publisher

PERGAMON-ELSEVIER SCIENCE LTD

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology 3211 Oncology and carcinogenesis Public Health and Health Services not elsewhere classified Oncology and Carcinogenesis not elsewhere classified

File(s) not publicly available

Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)

History

Journal

Volume

Pagination

Publisher DOI

ISSN

Language

Author URL

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports